olmesartan has been researched along with azilsartan in 12 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (azilsartan) | Trials (azilsartan) | Recent Studies (post-2010) (azilsartan) |
---|---|---|---|---|---|
841 | 185 | 554 | 124 | 25 | 116 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (91.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Giridhar, R; Murumkar, P; Naik, P; Yadav, MR | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Barrios, V; Escobar, C | 1 |
Bai, HY; Chisaka, T; Horiuchi, M; Iwanami, J; Kanno, H; Min, LJ; Mogi, M; Nakaoka, H; Ohshima, K; Tsukuda, K; Wang, XL | 1 |
di Mario, C; Francis, DP; Hayward, C; Krum, H; Lyon, AR; Ozdemir, BA; Patel, HC; Rosen, SD | 1 |
Hung, CS; Li-Ching, H; Miin-Jye, W; Shing, KK | 1 |
Asayama, K; Haga, T; Hosaka, M; Imai, Y; Inoue, R; Kikuya, M; Mano, N; Metoki, H; Murakami, T; Obara, T; Ohkubo, T; Satoh, M | 1 |
Arimoto, M; Hata, H; Osaka, S; Sakino, H; Sezai, A; Shiono, M; Yaoita, H | 1 |
Hanayama, Y; Kakio, Y; Okuyama, Y; Takeuchi, H; Uchida, HA; Umebayashi, R; Wada, J | 1 |
Adachi, S; Fujisawa, K; Hitaka, Y; Ideishi, M; Inoue, A; Inoue, K; Kusumoto, T; Kuwano, T; Miura, SI; Motozato, K; Norimatsu, K; Saku, K; Shiga, Y; Shirotani, T; Yano, M | 1 |
van der Merwe, WM | 1 |
Dong, P; Liu, H; Zhao, D | 1 |
4 review(s) available for olmesartan and azilsartan
Article | Year |
---|---|
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan | 2010 |
An evaluation of the latest evidence relating to renin-angiotensin system inhibitors.
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Fumarates; Humans; Imidazoles; Meta-Analysis as Topic; Neoplasms; Oxadiazoles; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Telmisartan; Tetrazoles | 2013 |
Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation.
Topics: Amides; Antihypertensive Agents; Benzimidazoles; Benzopyrans; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Control Groups; Double-Blind Method; Drug Resistance; Eplerenone; Ethanolamines; Fumarates; Humans; Hypertension; Imidazoles; Kidney; Nebivolol; Oxadiazoles; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Spironolactone; Sympathectomy; Tetrazoles; Treatment Outcome | 2015 |
Antihypertensive effect of azilsartan versus olmesartan in patients with essential hypertension: a meta-analysis.
Topics: Antihypertensive Agents; Benzimidazoles; Blood Pressure; Essential Hypertension; Humans; Imidazoles; Oxadiazoles; Tetrazoles | 2019 |
3 trial(s) available for olmesartan and azilsartan
Article | Year |
---|---|
Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Blood Pressure; Cardiac Surgical Procedures; Drug Substitution; Essential Hypertension; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Oxadiazoles; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Remodeling | 2016 |
Practical efficacy of olmesartan versus azilsartan in patients with hypertension: a multicenter randomized-controlled trial (MUSCAT-4 study).
Topics: Aged; Benzimidazoles; Blood Pressure; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles | 2017 |
Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Blood Pressure; Dose-Response Relationship, Drug; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Oxadiazoles; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome | 2017 |
5 other study(ies) available for olmesartan and azilsartan
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Cardiomegaly; Epithelial Sodium Channels; Imidazoles; Male; Mice; Mice, Inbred C57BL; Oxadiazoles; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sodium; Tetrazoles | 2014 |
Noninferiority studies with multiple reference treatments.
Topics: Benzimidazoles; Blood Pressure; Equivalence Trials as Topic; Humans; Hypertension; Imidazoles; Oxadiazoles; Reference Standards; Research Design; Sample Size; Tetrazoles; Treatment Outcome; Valsartan | 2017 |
The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Oxadiazoles; Self Care; Telmisartan; Tetrazoles; Time Factors; Valsartan | 2016 |
Treatment of hypertension in CKD patients with azilsartan/chlorthalidone vs olmesartan/hydrochlorothiazide.
Topics: Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Renal Insufficiency, Chronic; Tetrazoles | 2018 |